Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia
Lancet Haematol
.
2022 May;9(5):e317-e318.
doi: 10.1016/S2352-3026(22)00100-4.
Author
Gunnar Juliusson
1
Affiliation
1
Stem Cell Centre, Department of Laboratory Medicine, Lund University, Lund, S-22100 Lund, Sweden. Electronic address:
[email protected]
.
PMID:
35483394
DOI:
10.1016/S2352-3026(22)00100-4
No abstract available
Publication types
Comment
MeSH terms
Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
Humans
Leukemia, Myeloid, Acute* / drug therapy
Sulfonamides / therapeutic use
Substances
Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax